Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc D Ryser

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Breast Cancer Research : BCR|September 17, 2024
Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25)Elissa M Ozanne, Kellyn Maves, Angela C Tramontano, et al.
The British Journal of Surgery|August 30, 2024
Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort studySabrina M Wang, Yan Li, Amanda Nash, et al.
British Journal of Cancer|August 19, 2021
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breastMaartje van Seijen, Esther H Lips, Liping Fu, et al.
Radiology|January 10, 2023
Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in SituDanalyn Byng, Samantha M Thomas, Christel N Rushing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2020
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort ConsortiumJulia Butt, William J Blot, Kala Visvanathan, et al.
Cancer Research|October 9, 2025
Spatially Discontinuous Mutation Topographies in Ductal Carcinoma In Situ Reveal Noncompetitive Growth DynamicsMarc D Ryser, Matthew A Greenwald, Daniel Monyak, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast DevelopmentMarc D Ryser, Matthew A Greenwald, Inmaculada C Sorribes, et al.
Microorganisms|November 4, 2020
Association of Combined Sero-Positivity to <i>Helicobacter pylori</i> and <i>Streptococcus gallolyticus</i> with Risk of Colorectal CancerMeira Epplein, Loïc Le Marchand, Timothy L Cover, et al.
BMJ (Clinical Research Ed.)|October 30, 2023
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort studyRenée S J M Schmitz, Alexandra W van den Belt-Dusebout, Karen Clements, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Breast Cancer Research : BCR|September 17, 2024
Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25)Elissa M Ozanne, Kellyn Maves, Angela C Tramontano, et al.
The British Journal of Surgery|August 30, 2024
Disease-specific survival outcomes for patients after locoregional treatment for ductal carcinoma in situ: observational cohort studySabrina M Wang, Yan Li, Amanda Nash, et al.
British Journal of Cancer|August 19, 2021
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breastMaartje van Seijen, Esther H Lips, Liping Fu, et al.
Radiology|January 10, 2023
Surveillance Imaging after Primary Diagnosis of Ductal Carcinoma in SituDanalyn Byng, Samantha M Thomas, Christel N Rushing, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 25, 2020
Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a U.S. Prospective Cohort ConsortiumJulia Butt, William J Blot, Kala Visvanathan, et al.
Cancer Research|October 9, 2025
Spatially Discontinuous Mutation Topographies in Ductal Carcinoma In Situ Reveal Noncompetitive Growth DynamicsMarc D Ryser, Matthew A Greenwald, Daniel Monyak, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
Growth Dynamics of Ductal Carcinoma in Situ Recapitulate Normal Breast DevelopmentMarc D Ryser, Matthew A Greenwald, Inmaculada C Sorribes, et al.
Microorganisms|November 4, 2020
Association of Combined Sero-Positivity to <i>Helicobacter pylori</i> and <i>Streptococcus gallolyticus</i> with Risk of Colorectal CancerMeira Epplein, Loïc Le Marchand, Timothy L Cover, et al.
BMJ (Clinical Research Ed.)|October 30, 2023
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort studyRenée S J M Schmitz, Alexandra W van den Belt-Dusebout, Karen Clements, et al.
JAMA|December 12, 2024
Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical TrialE Shelley Hwang, Terry Hyslop, Thomas Lynch, et al.
Pageof 6